Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

View:
Post by ChiChi3 on Jun 24, 2010 1:21pm

Paladin

Why no movement on Paladin stock on this news?  I would have thought a 5-10% drop would have made sense...

Chi.
Comment by BornReady1970 on Jun 24, 2010 1:31pm
??? do you folow Paladin at all ???Anything that comes out of ISA will be considered "bonus" for them. They have a market cap of about $430m and own ~25% of ISA which has a market cap of $34m and yet you think it'll drive the share price 5-10%?Now, if Paladin ends up with the IP and ISA goes down before LUX is approved because of delays then you might see a very big upswing in share ...more  
Comment by ChiChi3 on Jun 24, 2010 2:02pm
Oops, no I don't follow Paladin and I mistakenly read their market cap to be under $100 million...my mistake.Chi.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities